Analyst: Walgreen-AmerisourceBergen alliance not likely to change the game

04/1/2013 | Drug Channels

Though Walgreen and Alliance Boots will gain purchasing power from a 10-year deal with drug distributor AmerisourceBergen, the alliance is not likely to result in a broad reshuffling of the industry, according to analysts at Lazard Capital Markets.

View Full Article in:

Drug Channels